FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

773879000: Antineoplastic therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3726859011 Antineoplastic therapeutic role en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3726860018 Antineoplastic therapeutic role (role) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antineoplastic therapeutic role Is a Therapeutic role (role) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only avapritinib in oral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Avapritinib-containing product in oral dose form Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing trastuzumab deruxtecan (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing only trastuzumab deruxtecan (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing trastuzumab deruxtecan in parenteral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing only trastuzumab deruxtecan in parenteral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing only enfortumab vedotin (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing enfortumab vedotin in parenteral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing enfortumab vedotin (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Enfortumab vedotin only product in parenteral dose form Plays role False Antineoplastic therapeutic role Inferred relationship Some
Tazemetostat only product Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing tazemetostat in oral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing tazemetostat (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing only tazemetostat in oral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing isatuximab (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing only isatuximab (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing isatuximab in parenteral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Isatuximab only product in parenteral dose form Plays role False Antineoplastic therapeutic role Inferred relationship Some
Ibrutinib 140 mg oral capsule Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing ibrutinib (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing ibrutinib in oral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing only ibrutinib in oral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Ibrutinib only product Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely palbociclib 125 milligram/1 each conventional release oral capsule (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing only palbociclib (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing only palbociclib in oral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing palbociclib (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Palbociclib-containing product in oral dose form Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely panobinostat (as panobinostat lactate) 15 milligram/1 each conventional release oral capsule (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Panobinostat (as panobinostat lactate) 10 mg oral capsule Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely ixazomib (as ixazomib citrate) 4 milligram/1 each conventional release oral capsule (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing ixazomib (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Ixazomib only product Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely panobinostat (as panobinostat lactate) 20 milligram/1 each conventional release oral capsule (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Ixazomib (as ixazomib citrate) 3 mg oral capsule Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely ixazomib (as ixazomib citrate) 2.3 milligram/1 each conventional release oral capsule (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Cabozantinib (as cabozantinib s-malate) 20 mg oral capsule Plays role False Antineoplastic therapeutic role Inferred relationship Some
Cabozantinib only product in oral dose form Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing cabozantinib (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing cabozantinib in oral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing only cabozantinib (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Palbociclib 75 mg oral capsule Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely palbociclib 100 milligram/1 each conventional release oral capsule (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely cabozantinib (as cabozantinib s-malate) 80 milligram/1 each conventional release oral capsule (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing only durvalumab in parenteral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing only durvalumab (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing durvalumab (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing durvalumab in parenteral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing only encorafenib (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Encorafenib only product in oral dose form Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing encorafenib (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Encorafenib-containing product in oral dose form Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing selumetinib (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Selumetinib only product Plays role False Antineoplastic therapeutic role Inferred relationship Some
Selumetinib-containing product in oral dose form Plays role False Antineoplastic therapeutic role Inferred relationship Some
Selumetinib only product in oral dose form Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely selumetinib 25 milligram/1 each conventional release oral capsule (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely selumetinib 10 milligram/1 each conventional release oral capsule (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Pemigatinib 4.5 mg oral tablet Plays role False Antineoplastic therapeutic role Inferred relationship Some
Pemigatinib 9 mg oral tablet Plays role False Antineoplastic therapeutic role Inferred relationship Some
Pemigatinib 13.5 mg oral tablet Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing only pemigatinib in oral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing pemigatinib in oral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing only pemigatinib (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing pemigatinib (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Tucatinib 50 mg oral tablet Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely tucatinib 150 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Tucatinib only product in oral dose form Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing tucatinib in oral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing only tucatinib (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing tucatinib (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Sacituzumab govitecan-containing product Plays role False Antineoplastic therapeutic role Inferred relationship Some
Sacituzumab govitecan only product Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing sacituzumab govitecan in parenteral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Sacituzumab govitecan only product in parenteral dose form Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing only olaparib in oral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Olaparib 150 mg oral tablet Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely olaparib 100 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Olaparib-containing product in oral dose form Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing only olaparib (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing olaparib (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Niraparib only product in oral dose form Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing only niraparib (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing niraparib (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing niraparib in oral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing only rucaparib (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Rucaparib only product in oral dose form Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing rucaparib (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing rucaparib in oral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing nivolumab in parenteral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Nivolumab only product in parenteral dose form Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing only nivolumab (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing nivolumab (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Ipilimumab-containing product in parenteral dose form Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing only ipilimumab in parenteral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Ipilimumab only product Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing ipilimumab (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Atezolizumab only product in parenteral dose form Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing atezolizumab (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing atezolizumab in parenteral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing only atezolizumab (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some

Start Page 2 of 17 Next End

This concept is not in any reference sets

Back to Start